Moreover, recent reports have shown that SALL4 positively regulated the expression of ABCA3, affecting the sensitivity to chemotherapy drug in chronic myeloid leukaemia [36]. This evidence concerns the gene ABCA3 and chronic myelogenous leukemia, BCR-ABL1 positive.